Mesenteric Venous Thrombosis

Journal of Clinical and Experimental Hepatology

Volumn 4, Issue 3, 2014, Pages 257-263

  Hmoud, Bashar ^a   Singal, Ashwani K ^b   Kamath, Patrick S ^c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Alabama at Birmingham   (United States)

^c MAYO CLINIC   (United States)

Author keywords

JAK2; Mesenteric venous thrombosis; MVT; Portal hypertension; PVT; Thrombosis; TIPS

Indexed keywords

JANUS KINASE 2; LOW MOLECULAR WEIGHT HEPARIN;

ANASTOMOSIS; ANTICOAGULANT THERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOPPLER FLOWMETRY; DRUG SAFETY; DRUG TOLERABILITY; FLUID THERAPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; INCIDENCE; INCIDENTAL FINDING; INTERVENTIONAL RADIOLOGY; MESENTERIC VEIN THROMBOSIS; MESENTERY BLOOD FLOW; MOLECULAR DIAGNOSIS; OUTCOME ASSESSMENT; PATHOGENESIS; REVIEW;

EID: 84908622694     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2014.03.052     Document Type: Review

References (49)

1. Grendell J.H., Ockner R.K. Mesenteric venous thrombosis. Gastroenterology 1982, 82:358-372.
2. Zhang J., Duan Z.Q., Song Q.B., Luo Y.W., Xin S.J., Zhang Q. Acute mesenteric venous thrombosis: a better outcome achieved through improved imaging techniques and a changed policy of clinical management. Eur J Vasc Endovasc Surg 2004, 28:329-334.
3. Harnik I.G., Brandt L.J. Mesenteric venous thrombosis. Vasc Med 2010, 15:407-418.
4. Singal A.K., Kamath P.S., Tefferi A. Mesenteric venous thrombosis. Mayo Clin Proc Mayo Clin 2013, 88:285-294.
5. Brunaud L., Antunes L., Collinet-Adler S., et al. Acute mesenteric venous thrombosis: case for nonoperative management. JVasc Surg 2001, 34:673-679.
6. Morasch M.D., Ebaugh J.L., Chiou A.C., Matsumura J.S., Pearce W.H., Yao J.S. Mesenteric venous thrombosis: a changing clinical entity. JVasc Surg 2001, 34:680-684.
7. Acosta S., Alhadad A., Svensson P., Ekberg O. Epidemiology, risk and prognostic factors in mesenteric venous thrombosis. Br J Surg 2008, 95:1245-1251.
8. Kumar S., Sarr M.G., Kamath P.S. Mesenteric venous thrombosis. NEngl J Med 2001, 345:1683-1688.
9. Colaizzo D., Amitrano L., Tiscia G.L., et al. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. JThromb Haemost 2007, 5:55-61.
10. Abdu R.A., Zakhour B.J., Dallis D.J. Mesenteric venous thrombosis-1911 to 1984. Surgery 1987, 101:383-388.
11. Harward T.R., Green D., Bergan J.J., Rizzo R.J., Yao J.S. Mesenteric venous thrombosis. JVasc Surg 1989, 9:328-333.
12. Condat B., Pessione F., Helene Denninger M., Hillaire S., Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000, 32:466-470.
13. Pabinger I., Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) study group on natural inhibitors. Arterioscler Thromb Vasc Biol 1996, 16:742-748.
14. Tripodi A., Mannucci P.M. The coagulopathy of chronic liver disease. NEngl J Med 2011, 365:147-156.
15. He J.A., Hu X.H., Fan Y.Y., et al. Hyperhomocysteinaemia, low folate concentrations and methylene tetrahydrofolate reductase C677T mutation in acute mesenteric venous thrombosis. Eur J Vasc Endovasc Surg 2010, 39:508-513.
16. Kumar S., Kamath P.S. Acute superior mesenteric venous thrombosis: one disease or two?. Am J gastroenterology 2003, 98:1299-1304.
17. Boley S.J., Kaleya R.N., Brandt L.J. Mesenteric venous thrombosis. Surg Clin North Am 1992, 72:183-201.
18. Rhee R.Y., Gloviczki P., Mendonca C.T., et al. Mesenteric venous thrombosis: still a lethal disease in the 1990s. JVasc Surg 1994, 20:688-697.
19. Liddington M.I., Thomson W.H. Rebound tenderness test. Br J Surg 1991, 78:795-796.
20. Prout W.G. The significance of rebound tenderness in the acute abdomen. Br J Surg 1970, 57:508-510.
21. Gehl H.B., Bohndorf K., Klose K.C., Günther R.W. Two-dimensional MR angiography in the evaluation of abdominal veins with gradient refocused sequences. JComput Assist Tomogr 1990, 14:619-624.
22. Haddad M.C., Clark D.C., Sharif H.S., al Shahed M., Aideyan O., Sammak B.M. MR, CT, and ultrasonography of splanchnic venous thrombosis. Gastrointest Radiol 1992, 17:34-40.
23. Milone M., Di Minno M.N., Musella M., et al. Computed tomography findings of pneumatosis and portomesenteric venous gas in acute bowel ischemia. World J Gastroenterol: WJG 2013, 19:6579-6584.
24. Grisham A., Lohr J., Guenther J.M., Engel A.M. Deciphering mesenteric venous thrombosis: imaging and treatment. Vasc Endovascular Surg 2005, 39:473-479.
25. Primignani M., Barosi G., Bergamaschi G., et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 2006, 44:1528-1534.
26. Naitove A., Weismann R.E. Primary mesenteric venous thrombosis. Ann Surg 1965, 161:516-523.
27. Plessier A., Darwish-Murad S., Hernandez-Guerra M., et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010, 51:210-218.
28. Clark N.P., Delate T., Riggs C.S., et al. Warfarin interactions with antibiotics in the Ambulatory Care Setting. JAMA Intern Med 2014, 174:409-416.
29. Daly A.K. Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms. Arch Toxicol 2013, 87:407-420.
30. Garcia D.A. Patients with stable, therapeutic INR values should remain on warfarin. JThromb Thrombolysis 2013, 35:336-338.
31. Thatipelli M.R., McBane R.D., Hodge D.O., Wysokinski W.E. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol 2010, 8:200-205.
32. al Karawi M.A., Quaiz M., Clark D., Hilali A., Mohamed A.E., Jawdat M. Mesenteric vein thrombosis, non-invasive diagnosis and follow-up (US+ MRI), and non-invasive therapy by streptokinase and anticoagulants. Hepatogastroenterology 1990, 37:507-509.
33. Robin P., Gruel Y., Lang M., Lagarrigue F., Scotto J.M. Complete thrombolysis of mesenteric vein occlusion with recombinant tissue-type plasminogen activator. Lancet 1988, 1:1391.
34. Hollingshead M., Burke C.T., Mauro M.A., Weeks S.M., Dixon R.G., Jaques P.F. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. JVasc Interv Radiol 2005, 16:651-661.
35. Smalberg J.H., Spaander M.V., Jie K.S., et al. Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis. Thromb Haemost 2008, 100:1084-1088.
36. Kim H.S., Patra A., Khan J., Arepally A., Streiff M.B. Transhepatic catheter-directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosis. JVasc Interv Radiol 2005, 16:1685-1691.
37. Yankes J.R., Uglietta J.P., Grant J., Braun S.D. Percutaneous transhepatic recanalization and thrombolysis of the superior mesenteric vein. AJR Am J Roentgenol 1988, 151:289-290.
38. Wang M.Q., Liu F.Y., Duan F., Wang Z.J., Song P., Fan Q.S. Acute symptomatic mesenteric venous thrombosis: treatment by catheter-directed thrombolysis with transjugular intrahepatic route. Abdom Imaging 2011, 36:390-398.
39. Semiz-Oysu A., Keussen I., Cwikiel W. Interventional radiological management of prehepatic obstruction of [corrected] the splanchnic venous system. Cardiovasc Intervent Radiol 2007, 30:688-695.
40. Sehgal M., Haskal Z.J. Use of transjugular intrahepatic portosystemic shunts during lytic therapy of extensive portal splenic and mesenteric venous thrombosis: long-term follow-up. JVasc Interv Radiol 2000, 11:61-65.
41. Walser E.M., NcNees S.W., DeLa Pena O., et al. Portal venous thrombosis: percutaneous therapy and outcome. JVasc Interv Radiol 1998, 9:119-127.
42. Ganger D.R., Klapman J.B., McDonald V., et al. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol 1999, 94:603-608.
43. Kaplan J.L., Weintraub S.L., Hunt J.P., Gonzalez A., Lopera J., Brazzini A. Treatment of superior mesenteric and portal vein thrombosis with direct thrombolytic infusion via an operatively placed mesenteric catheter. Am Surg 2004, 70:600-604.
44. Bulkley G.B., Zuidema G.D., Hamilton S.R., O'Mara C.S., Klacsmann P.G., Horn S.D. Intraoperative determination of small intestinal viability following ischemic injury: a prospective, controlled trial of two adjuvant methods (Doppler and fluorescein) compared with standard clinical judgment. Ann Surg 1981, 193:628-637.
45. Schoots I.G., Koffeman G.I., Legemate D.A., Levi M., van Gulik T.M. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg 2004, 91:17-27.
46. Amitrano L., Guardascione M.A., Scaglione M., et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007, 102:2464-2470.
47. Dentali F., Ageno W., Witt D., et al. Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study. Thromb Haemost 2009, 102:501-504.
48. Orr D.W., Harrison P.M., Devlin J., et al. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up. Clin Gastroenterol Hepatol 2007, 5:80-86.
49. Diman R.K., Behera A., Chawla Y.K., et al. Portal hypertensive biliopathy. Gut 2007, 56:1001-1008.